Does a broad pattern of pathogen-specific IgG suggest prior exposure rather than active infection?

Pathogen-specific IgG testing is most useful as evidence of immunologic history, not as a stand-alone indicator of whether a pathogen is currently replicating or causing illness. This distinction is especially important when multiple serologies are positive.

Clinical interpretation

• IgG commonly persists long after infection resolution because long-lived plasma cells maintain antibody production; persistence may be decades or lifelong. Examples include lifelong EBV viral-capsid-antigen IgG, CMV IgG indicating infection at some point, and parvovirus B19 IgG consistent with prior exposure.
• A single positive IgG result does not date infection or establish active disease. For tick-borne and rickettsial illnesses, including Ehrlichia, Rickettsia-related infections, and Lyme borreliosis, antibodies can remain detectable for months to years.
• When recent infection is a concern, stronger evidence may include paired acute and convalescent samples showing a fourfold IgG titre rise, an appropriate IgM/IgG/antigen-specific pattern (for example, EBV VCA and EBNA), or pathogen-specific direct detection such as PCR/NAAT alongside compatible symptoms and exposures.

Mechanistic and assay considerations

• Broad IgG reactivity can reflect genuine accumulated exposures, but it is not necessarily evidence of numerous distinct infections. Vaccination may produce pathogen-specific antibodies without natural infection.
• Antibody cross-reactivity can generate false-positive signals when antibodies recognize antigens from related—and sometimes unrelated—targets.
• Polyclonal B-cell activation, reported in settings such as EBV infection or malaria, can produce antibodies reactive with unrelated antigens and contribute to multiple positive serologic findings.

Bottom line

• Broad pathogen-specific IgG positivity generally supports prior immune exposure, but it neither identifies when exposure occurred nor independently establishes current active infection. Clinical syndrome, exposure history, assay characteristics, serial testing, and appropriately timed direct pathogen testing determine whether active infection is present.